newsfilter
← Latest News
GlobeNewswire·

ARS Pharmaceuticals to Participate in Piper Sandler 37th Annual Healthcare Conference

  • ARS Pharmaceuticals, Inc. will participate in the Piper Sandler 37th Annual Healthcare Conference on December 2-4, 2025, in New York.
  • CEO Richard Lowenthal & Chief Commercial Officer Eric Karas will join Piper Sandler analyst David Amsellem for a fireside chat on Wednesday, December 3, at 2:30 pm ET.
  • The company management will hold one-on-one meetings with investors during the event.
  • A live webcast of the fireside chat will be available via a link on the company's website, with a replay archived for 90 days.
  • ARS Pharmaceuticals is commercializing neffy®, an epinephrine nasal spray for emergency treatment of Type I allergic reactions & anaphylaxis in the U.S. & EU.
  • In the U.S., neffy® is indicated for adult & pediatric patients 4 years of age & older weighing 33 lbs. or greater.
  • In the EU, neffy® (EUR neffy®) is indicated for adults & children weighing 30 kg or greater for anaphylaxis caused by insect stings, bites, foods, medicinal products, or other allergens.